EQ
$5.76
Equillium
$.10
1.77%
EQ
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.41)
Revenue:  $0.00 Mil
Tuesday
Nov 10
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when EQ reports earnings?
Beat
Meet
Miss

Where is EQ's stock price going from here?
Up
Flat
Down
Stock chart of EQ
Analysts
Summary of analysts' recommendations for EQ
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Equillium, Inc. is a biotechnology company. It develops products for autoimmune and inflammatory disorders. The company's product pipeline consists of EQ001 which is in clinical-stage. Equillium, Inc. is based in CA, United States.